Blog Post

Blog Post

MDA Grants Charles Thornton More Than $1 Million in New Funding to Continue Supporting the Myotonic Dystrophy Clinical Research Network

By Jeanene Swanson | October 25, 2019
Blog Post

Reporting Back from the MDA Public Policy and Advocacy Conference — and Keeping Up the Momentum

By Chris Anselmo | October 24, 2019
Blog Post

Five Questions with DMD Researcher Matthew Wood

By Jeanene Swanson | October 23, 2019
Blog Post

ReveraGen Presents Positive Interim Results from Phase 2 Extension Study of Vamorolone to Treat DMD in Young Boys

By Jeanene Swanson | October 21, 2019
Blog Post

Clinical Trial Alert: Amicus Therapeutics Seeks Participants for a Phase 3 Late-Onset Pompe Disease Study

By MDA Staff | October 16, 2019
Blog Post

Clinical Trial Alert: Momenta Pharmaceuticals Seeks Participants for a Phase 2 Myasthenia Gravis Study

By MDA Staff | October 15, 2019
Blog Post

Casey’s General Stores Round Up for MDA

By MDA Staff | October 15, 2019
Blog Post

Amy and Jamie Shinneman Find Purpose on Their Way to the Bank of America Chicago Marathon

By Lindsey Baker | October 7, 2019
Blog Post

NS Pharma Submits New Drug Application to FDA for Viltolarsen to Treat DMD Amenable to Exon 53 Skipping

By Jeanene Swanson | October 7, 2019
Blog Post

At a Cedars-Sinai Care Center, Dr. Robert Baloh Looks Under — and Ahead of — the Microscope for CMT and ALS

By Lindsey Baker | October 1, 2019